retatrutide latest news 🚨Breaking: Retatrutide's first Phase 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Company linked to raid on

FDA may issue no objection (the company may market, though this is not approval) or object (e.g., safety concerns or incomplete data)

Participation in the BALANCE Model is voluntary for drug manufacturers, state Medicaid programs, and Medicare Part D plans, but there was insufficient interest among Medicare Part D plans to move forward in 2027 Participation in BALANCE is voluntary for drug manufacturers, state Medicaid agencies, and Medicare Part D plans

Photo Credit: Adobe Stock 35 mins These protein-packed muffins combine eggs, lean turkey sausage, fresh spinach, and bell peppers for a savory start to your day

Next steps: continue advancing TIX100 in #T1D while further exploring its potential role in #weightmaintenance

Active GLP-1 (7-36) amide Chemiluminescence ELISA Catalog The STELLUX Chemi Active GLP-1 (7-36) amide ELISA is intended for the quantitative determination of active GLP- 1 (7-36) amide in human, mouse, and rat EDTA plasma samples collected in the presence of DPP-4 inhibitor